Seroprevalence of SARS-CoV-2 in Niger State: Pilot Cross-Sectional Study

Seroprevalence of SARS-CoV-2 in Niger State: Pilot Cross-Sectional Study

Authors of this article:

Hussaini Majiya^{1, 2, 3} ;   Mohammed Aliyu-Paiko^{2, 3, 4} ;   Vincent Tochukwu Balogu^{1, 2} ;   Dickson Achimugu Musa^{2, 3, 4} ;   Ibrahim Maikudi Salihu^{2, 5} ;   Abdullahi Abubakar Kawu^{2, 3, 6} ;   Ishaku Yakubu Bashir^{2, 7} ;   Aishat Rabiu Sani^{1, 2, 3} ;   John Baba^{1, 2} ;   Amina Tako Muhammad^{2, 8} ;   Fatimah Ladidi Jibril^{1, 2} ;   Ezekiel Bala^{1, 2} ;   Nuhu George Obaje² ;   Yahaya Badeggi Aliyu^{2, 8} ;   Ramatu Gogo Muhammad^{1, 2} ;   Hadiza Mohammed^{2, 4} ;   Usman Naji Gimba^{2, 5} ;   Abduljelili Uthman^{2, 4} ;   Hadiza Muhammad Liman^{2, 7} ;   Sule Alfa Alhaji⁹ ;   Joseph Kolo James¹⁰ ;   Muhammad Muhammad Makusidi¹⁰ ;   Mohammed Danasabe Isah⁹ ;   Ibrahim Abdullahi^{2, 6} ;   Umar Ndagi^{3, 9, 11} ;   Bala Waziri¹¹ ;   Chindo Ibrahim Bisallah¹ ;   Naomi John Dadi-Mamud^{2, 5} ;   Kolo Ibrahim^{1, 2} ;   Abu Kasim Adamu^{2, 5}